Tazemetostat: Phase I started

Epizyme began an open-label, international Phase I trial of oral tazemetostat in 28-day cycles in about

Read the full 164 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE